Pharmacological evaluation of water soluble cannabinoids and related analogs
- 1 January 1990
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 46 (22), 1575-1585
- https://doi.org/10.1016/0024-3205(90)90391-4
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuanaNeuropharmacology, 1987
- Correlation Between the Psychotropic Potency of Cannabinoids and Their Effect on the 1H-NMR Spectra of Model MembranesJournal of Pharmaceutical Sciences, 1983
- Levonantradol: A Role for Central Prostanoid Mechanisms?The Journal of Clinical Pharmacology, 1981
- The non-specific membrane binding properties of ΔA9-tetrahydrocannabinol and the effects of various solubilizersJournal of Pharmacy and Pharmacology, 1979
- Evidence for the existence of specific cannabinoid binding sitesLife Sciences, 1978
- Physicochemical Properties, Solubility, and Protein Binding of Δ9 -TetrahydrocannabinolJournal of Pharmaceutical Sciences, 1974
- The Membrane Binding of Morphine, Diphenylhydantoin, and TetrahydrocannabinolCanadian Journal of Physiology and Pharmacology, 1972
- Brain levels of Δ1-tetrahydrocannabinol and its metabolites in mice—correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxideBiochemical Pharmacology, 1972
- Water-Soluble Derivatives of Δ 1 -TetrahydrocannabinolScience, 1972
- STRUCTURAL REQUIREMENTS FOR CANNABINOID ACTIVITY*Annals of the New York Academy of Sciences, 1971